Victory Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.8M | Buy |
219,118
+94,192
| +75% | +$16.3M | 0.02% | 650 |
|
2025
Q1 | $19.5M | Sell |
124,926
-6,427
| -5% | -$1M | 0.02% | 819 |
|
2024
Q4 | $18.1M | Sell |
131,353
-2,505
| -2% | -$345K | 0.02% | 886 |
|
2024
Q3 | $20M | Sell |
133,858
-551
| -0.4% | -$82.3K | 0.02% | 847 |
|
2024
Q2 | $18.3M | Sell |
134,409
-155
| -0.1% | -$21.1K | 0.02% | 841 |
|
2024
Q1 | $20.3M | Buy |
+134,564
| New | +$20.3M | 0.02% | 813 |
|
2021
Q2 | – | Sell |
-518,396
| Closed | -$66.8M | – | 2745 |
|
2021
Q1 | $66.8M | Buy |
518,396
+10,638
| +2% | +$1.37M | 0.07% | 422 |
|
2020
Q4 | $84.7M | Buy |
507,758
+142,341
| +39% | +$23.7M | 0.09% | 319 |
|
2020
Q3 | $56.4M | Sell |
365,417
-33,021
| -8% | -$5.1M | 0.07% | 424 |
|
2020
Q2 | $58.9M | Sell |
398,438
-404,614
| -50% | -$59.8M | 0.08% | 369 |
|
2020
Q1 | $90.4M | Buy |
803,052
+258,087
| +47% | +$29.1M | 0.08% | 369 |
|
2019
Q4 | $75.8M | Buy |
544,965
+106,451
| +24% | +$14.8M | 0.09% | 315 |
|
2019
Q3 | $42.2M | Buy |
438,514
+97,606
| +29% | +$9.4M | 0.05% | 515 |
|
2019
Q2 | $39.3M | Buy |
340,908
+18,190
| +6% | +$2.09M | 0.08% | 387 |
|
2019
Q1 | $38M | Buy |
322,718
+299,400
| +1,284% | +$35.2M | 0.09% | 366 |
|
2018
Q4 | $1.46M | Sell |
23,318
-420
| -2% | -$26.3K | ﹤0.01% | 1115 |
|
2018
Q3 | $1.68M | Sell |
23,738
-1,240
| -5% | -$87.9K | ﹤0.01% | 1136 |
|
2018
Q2 | $1.66M | Sell |
24,978
-1,360
| -5% | -$90.5K | ﹤0.01% | 1116 |
|
2018
Q1 | $1.72M | Buy |
26,338
+8,970
| +52% | +$587K | ﹤0.01% | 1108 |
|
2017
Q4 | $696K | Buy |
17,368
+12,010
| +224% | +$481K | ﹤0.01% | 1288 |
|
2017
Q3 | $194K | Buy |
+5,358
| New | +$194K | ﹤0.01% | 1541 |
|
2017
Q2 | – | Sell |
-5,158
| Closed | -$144K | – | 1809 |
|
2017
Q1 | $144K | Buy |
+5,158
| New | +$144K | ﹤0.01% | 1521 |
|